EMA Verdict Due On Vertex/CRISPR’s Gene Editing Therapy & Reata’s Omaveloxolone

 
• By Vibha Sharma
  
Crispr-cas9 biotechnology dna gene engineering and manipulation. Modern Innovative Healthcare. Crispr cas.
Exa-Cel is made specifically for each patient, using their edited blood stem cells • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography